Anti-DLL4 [61B]

CAT: 0013-GTR18320663Size: 0.2 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR18320663Size:0.2 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Anti-DLL4 [61B]

Product Name Alternative

Delta-like protein 4; Drosophila Delta homolog 4; Delta4

UniProt

Q9NR61

Reactivity

Human

Immunogen

The original antibody was generated by immunizing mice with soluble human Dll4-His protein.

Target

DLL4

Clonality

Monoclonal

Clone

61B

Conjugation

Unconjugated

Field of Research

Cancer Biology

Concentration

1 mg/ml

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

Blocking, ELISA, IF, IHC

Host or Source

Mouse

Preservative

PBS with 0.02% Proclin 300.

Isotype

IgG

Related Products

Catalog	Name
GTR18623068-01	Anti-human DLL4 (Smart Targeting patent Anti-DLL4 Biosimilar)
GTR18320661	Anti-DLL4 [2-6]
GTR17698781	Goat anti-DLL4 Antibody
GTR18320662	Anti-DLL4 [2-6]
GTR18623446-01	Anti-human DLL4 (Enoticumab Biosimilar)
GTR18622944-01	Anti-human DLL4 (Demcizumab Biosimilar)
GTR18622943-01	Anti-human DLL4 (Navicixizumab Biosimilar)
GTR18915575	DLL4 Peptide
GTR18241724-01	DLL4 Antibody
GTR18311869-01	DLL4 Antibody

Catalog	Name
MBS489050-01	Anti-DLL4 [61B]
F1970-1	Anti-DLL4 Antibody (Smart Targeting patent anti-DLL4)
E24CHA797	Anti-DLL4 Reference Antibody (Smart Targeting anti-DLL4)
A00875-1	Anti-DLL4 Antibody
MBS1802311-01	Anti-DLL4 APC
MBS1801928-01	Anti-DLL4 PE
11-717-C100	Anti-DLL4 Purified
C00315-01	Demcizumab (Anti-DLL4)
C00606-1mg*25	Enoticumab (Anti-DLL4)
A2519-1mg	Navicixizumab (Anti-DLL4)